eligibility for glp-1 BMI and Weight Loss Treatment: What BMI Qualifies? NEW FOR 2026: Medicare GLP-1

Well Differentiated Neuroendocrine Carcinoma (Typical Carcinoid) with Mediastinal Lymph Node Metastases: Surgical Outcomes and Whole Exome Sequencing (WES)

Bariatric surgery is more cost-effective than GLP-1 drugs April 29, 2024 Source: Haseeb, et al JAMA Network Open April 12, 2024 LINK GLP-1 drugs are highly effective, and on average people are able to lose about 15% of their body weight with weekly self-injections

The complex genetic basis of plasma triglycerides

Npj Digit Med

FASEB J 26(6):23832393

It runs from July 1, 2026, through December 31, 2027, and gives eligible people with Medicare prescription drug coverage (Part D) access to select GLP-1 medications for weight loss